Meiji Yasuda Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,064
| Closed | -$338K | – | 689 |
|
|
2024
Q3 | $338K | Buy |
5,064
+177
| +4% | +$11.8K | 0.01% | 523 |
|
|
2024
Q2 | $580K | Buy |
4,887
+287
| +6% | +$34.1K | 0.02% | 399 |
|
|
2024
Q1 | $490K | Buy |
4,600
+850
| +23% | +$90.6K | 0.02% | 436 |
|
|
2023
Q4 | $373K | Buy |
3,750
+140
| +4% | +$13.9K | 0.02% | 437 |
|
|
2023
Q3 | $373K | Buy |
3,610
+393
| +12% | +$40.6K | 0.02% | 482 |
|
|
2023
Q2 | $391K | Sell |
3,217
-138
| -4% | -$16.8K | 0.02% | 456 |
|
|
2023
Q1 | $515K | Sell |
3,355
-130
| -4% | -$20K | 0.03% | 396 |
|
|
2022
Q4 | $626 | Sell |
3,485
-210
| -6% | -$38 | 0.03% | 390 |
|
|
2022
Q3 | $437K | Sell |
3,695
-520
| -12% | -$61.5K | 0.03% | 439 |
|
|
2022
Q2 | $602K | Buy |
4,215
+310
| +8% | +$44.3K | 0.03% | 410 |
|
|
2022
Q1 | $673K | Sell |
3,905
-293
| -7% | -$50.5K | 0.04% | 397 |
|
|
2021
Q4 | $1.07M | Sell |
4,198
-5,349
| -56% | -$1.36M | 0.07% | 264 |
|
|
2021
Q3 | $3.67M | Buy |
9,547
+497
| +5% | +$191K | 0.26% | 101 |
|
|
2021
Q2 | $2.13M | Buy |
9,050
+6,230
| +221% | +$1.46M | 0.1% | 162 |
|
|
2021
Q1 | $369K | Buy |
+2,820
| New | +$369K | 0.03% | 399 |
|
|
2020
Q3 | – | Sell |
-3,600
| Closed | -$231K | – | 418 |
|
|
2020
Q2 | $231K | Buy |
+3,600
| New | +$231K | 0.02% | 431 |
|